Atlas Trials

Syntrix Biosystems, Inc.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Syntrix Biosystems, Inc.

RecordFirmDate
Study of SX-682 Plus Enzalutamide in Men With ARPI-Resistant Metastatic Castration Resistant Prostate Cancer (NCT06228053)Syntrix Biosystems, Inc.2024-11-18
A Randomized Study Investigating Oral Desmetramadol Dose Proportionality and Food Effect In Normal Human Subjects (NCT04683926)Syntrix Biosystems, Inc.2021-01-08
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome (NCT04245397)Syntrix Biosystems, Inc.2020-06-30
SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab (NCT03161431)Syntrix Biosystems, Inc.2019-06-12
Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy (NCT03664921)Syntrix Biosystems, Inc.2018-11-15
Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis (NCT03431974)Syntrix Biosystems, Inc.2018-11-01
Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers (NCT03312777)Syntrix Biosystems, Inc.2017-10-31

Track Syntrix Biosystems, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.